Many online sellers of compounded GLP-1 receptor agonists may be misleading customers, a cross-sectional study suggested. Out ...

Meanwhile, Sage reported failed phase 2 trials of dalzanemdor in Alzheimer's, Parkinson's, and Huntington's disease, and ...

Humana Inc. fell short of pleading standards in its racketeering lawsuit against Biogen Inc. over its allegedly fraudulent ...

This week's stock market saw the S&P 500 rise 3.4%, fueled by positive inflation data and strong earnings reports.

Biogen has revealed encouraging phase 2 results with its anti-CD38 antibody felzartamab in rare kidney disease IgA nephropathy (IgAN), which it hopes could join a series of first-in-class ...

The Justice Department has filed a civil lawsuit accusing Walgreens of illegally dispensing millions of prescriptions for ...

US biotech Sage Therapeutics on Friday sued Biogen, a week after the biotech giant made an unsolicited offer to acquire the smaller neuroscience company for about $469 million, according to a ...

SPORT NEWS - The pre-race favourite Alan Hatherly surged away from Tristan Nortje, with 40 kilometres to race in the Momentum ...